CN Patent

CN119775192B — 一种三苯乙酸雷芬那辛晶型及其制备方法

Assigned to Jewim Pharmaceutical Shandong Co ltd · Expires 2025-11-28 · 0y expired

What this patent protects

本发明属于药物化学技术领域，具体涉及三苯乙酸雷芬那辛晶型及其制备方法。该晶型具有良好的化学稳定性和晶型纯度，易于规模化制备，能够更好地适用于制备药物制剂和规模化生产，具有广阔的应用前景。

USPTO Abstract

本发明属于药物化学技术领域，具体涉及三苯乙酸雷芬那辛晶型及其制备方法。该晶型具有良好的化学稳定性和晶型纯度，易于规模化制备，能够更好地适用于制备药物制剂和规模化生产，具有广阔的应用前景。

Drugs covered by this patent

Patent Metadata

Patent number
CN119775192B
Jurisdiction
CN
Classification
—
Expires
2025-11-28
Drug substance claim
No
Drug product claim
No
Assignee
Jewim Pharmaceutical Shandong Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.